Really leverages machine learning and neuroscience to non-invasively monitor and assess brain health, detecting early symptoms of neuropsychiatric disorders.
Really leverages machine learning and neuroscience to non-invasively monitor and assess brain health, detecting early symptoms of neuropsychiatric disorders. The company analyzes longitudinal medical, behavioral, and contextual data derived from language to provide scalable, low-friction solutions for early detection and objective measurement of preclinical symptoms.
Really has made significant strides in integrating advanced computational techniques with practical health monitoring, impacting the early diagnosis and management of neuropsychiatric conditions. The company's innovative approach has garnered attention and support from the medical and tech communities, positioning it as a leader in digital health diagnostics.
